-
1
-
-
0026491014
-
Bone-resorption markers galactosyl hydroxylysine. Pyridinium crosslinks, and hydroxyproline compared
-
Bettica P, Moro L, Robins SP, Taylor J, Singer FR and Baylink DJ (1992) Bone-resorption markers galactosyl hydroxylysine. pyridinium crosslinks, and hydroxyproline compared. Clin Chem 38: 2313-3218
-
(1992)
Clin Chem
, vol.38
, pp. 2313-3218
-
-
Bettica, P.1
Moro, L.2
Robins, S.P.3
Taylor, J.4
Singer, F.R.5
Baylink, D.J.6
-
2
-
-
0023137823
-
The clinical course of bone metastases from breast cancer
-
Coleman RE and Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55; 61-66
-
(1987)
Br J Cancer
, vol.55
, pp. 61-66
-
-
Coleman, R.E.1
Rubens, R.D.2
-
3
-
-
0023718844
-
Biochemical prediction of response of bone metastases to treatment
-
Coleman RE, Whittaker KB, Moss DW, Mashiter G, Fogelman I and Rubens RD (1988) Biochemical prediction of response of bone metastases to treatment. Br J Cancer 58: 205-210
-
(1988)
Br J Cancer
, vol.58
, pp. 205-210
-
-
Coleman, R.E.1
Whittaker, K.B.2
Moss, D.W.3
Mashiter, G.4
Fogelman, I.5
Rubens, R.D.6
-
4
-
-
0026508311
-
Preliminary results of the use of urinary secretion of pyridinium cross links for monitoring metastatic bone disease
-
Coleman RE, Houston S, James I, Rodger A, Rubens RD, Leonard REF and Ford J (1992) Preliminary results of the use of urinary secretion of pyridinium cross links for monitoring metastatic bone disease. Br J Cancer 65: 766-768
-
(1992)
Br J Cancer
, vol.65
, pp. 766-768
-
-
Coleman, R.E.1
Houston, S.2
James, I.3
Rodger, A.4
Rubens, R.D.5
Leonard, R.E.F.6
Ford, J.7
-
5
-
-
0027276213
-
Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption
-
Colwell A, Russell RGG and Eastell R (1993) Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest 23: 341-349
-
(1993)
Eur J Clin Invest
, vol.23
, pp. 341-349
-
-
Colwell, A.1
Russell, R.G.G.2
Eastell, R.3
-
6
-
-
0025878928
-
Urinary excretion of pyridinium crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis
-
Delmas PD, Schlemmer A, Gineyts E, Riis B and Christiansen C (1991) Urinary excretion of pyridinium crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Min Res 6: 639-644
-
(1991)
J Bone Min Res
, vol.6
, pp. 639-644
-
-
Delmas, P.D.1
Schlemmer, A.2
Gineyts, E.3
Riis, B.4
Christiansen, C.5
-
7
-
-
0025103376
-
Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate
-
Dodwell DJ, Howell A and Ford J (1990) Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate. Br J Cancer 61: 213-215
-
(1990)
Br J Cancer
, vol.61
, pp. 213-215
-
-
Dodwell, D.J.1
Howell, A.2
Ford, J.3
-
8
-
-
0031019020
-
Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetics studies in osteoporosis
-
Eastell R, Hampton L, Colwell A and Reeve J (1997) Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetics studies in osteoporosis. JBMR 12: 59-65
-
(1997)
JBMR
, vol.12
, pp. 59-65
-
-
Eastell, R.1
Hampton, L.2
Colwell, A.3
Reeve, J.4
-
9
-
-
0026531795
-
New biomarkers of bone resorption
-
Eyre DR (1990) Editorial; New biomarkers of bone resorption. J Clin Endocrinol Metab 74: 470A-470C
-
(1990)
J Clin Endocrinol Metab
, vol.74
-
-
Eyre, D.R.1
-
10
-
-
0019304813
-
Evidence for natural existence and pyridinoline crosslink in collagen
-
Fujimoto D (1980) Evidence for natural existence and pyridinoline crosslink in collagen. Biochem Res Commun 93: 948-953
-
(1980)
Biochem Res Commun
, vol.93
, pp. 948-953
-
-
Fujimoto, D.1
-
11
-
-
0017345746
-
Assessment of response to therapy in advanced breast cancer
-
Hayward JL, Carbone PP, Henson JC, Kumaoka S, Segaloff A and Rubens RD (1977) Assessment of response to therapy in advanced breast cancer. Cancer 39: 1289-1293
-
(1977)
Cancer
, vol.39
, pp. 1289-1293
-
-
Hayward, J.L.1
Carbone, P.P.2
Henson, J.C.3
Kumaoka, S.4
Segaloff, A.5
Rubens, R.D.6
-
12
-
-
0027459757
-
Biochemical markers for detecting bone metastases in patients with breast cancer
-
Moro L, Gazzarrini C, Crivellari D, Galligioni E, Talamini R and de Bernard B (1993) Biochemical markers for detecting bone metastases in patients with breast cancer. Clin Chem 39: 131-134
-
(1993)
Clin Chem
, vol.39
, pp. 131-134
-
-
Moro, L.1
Gazzarrini, C.2
Crivellari, D.3
Galligioni, E.4
Talamini, R.5
De Bernard, B.6
-
13
-
-
0022390810
-
Tumour products and the hypercalcaemia of malignancy
-
Mundy GR, Ibbotsin KJ and D'Souza SM (1985) Tumour products and the hypercalcaemia of malignancy. J Clin Invest 76: 391-394
-
(1985)
J Clin Invest
, vol.76
, pp. 391-394
-
-
Mundy, G.R.1
Ibbotsin, K.J.2
D'Souza, S.M.3
-
14
-
-
0026001891
-
Pyridinium crosslinks as markers of bone resorption in patients with breast cancer
-
Paterson CR, Robins SP, Horobin JM, Preece PE and Cuschieri A (1991) Pyridinium crosslinks as markers of bone resorption in patients with breast cancer. Br J Cancer 64: 884-886
-
(1991)
Br J Cancer
, vol.64
, pp. 884-886
-
-
Paterson, C.R.1
Robins, S.P.2
Horobin, J.M.3
Preece, P.E.4
Cuschieri, A.5
-
15
-
-
0014687147
-
Relation between serum and urinary calcium with particular reference to parathyroid activity
-
Peacock M, Robertson WG and Nordin BEC (1969) Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet i: 384-386
-
(1969)
Lancet
, vol.1
, pp. 384-386
-
-
Peacock, M.1
Robertson, W.G.2
Nordin, B.E.C.3
-
16
-
-
38249015701
-
Role of assays for parathyroid hormone-related protein in investigation of hypercalcaemia
-
Ratcliffe WA, Hutchensson ACJ, Bundred NJ and Ratcliffe JG (1992) Role of assays for parathyroid hormone-related protein in investigation of hypercalcaemia. Lancet 339: 164-167
-
(1992)
Lancet
, vol.339
, pp. 164-167
-
-
Ratcliffe, W.A.1
Hutchensson, A.C.J.2
Bundred, N.J.3
Ratcliffe, J.G.4
-
18
-
-
0025832350
-
Objective measurement of therapeutic response in breast cancer using tumour markers
-
Robertson JF, Pearson D, Price MR, Selby C, Blamey RW and Howell A (1991) Objective measurement of therapeutic response in breast cancer using tumour markers. Br J Cancer 64; 757-763
-
(1991)
Br J Cancer
, vol.64
, pp. 757-763
-
-
Robertson, J.F.1
Pearson, D.2
Price, M.R.3
Selby, C.4
Blamey, R.W.5
Howell, A.6
-
19
-
-
0002004075
-
Turnover and crosslinking in collagen
-
Weiss JB and Jayson MIV (eds), Churchill Livingstone; Edinburgh
-
Robins SP (1982) Turnover and crosslinking in collagen. In: Collagen in Health and Disease, Weiss JB and Jayson MIV (eds), pp. 160. Churchill Livingstone; Edinburgh
-
(1982)
Collagen in Health and Disease
, pp. 160
-
-
Robins, S.P.1
-
20
-
-
0028122747
-
Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis
-
Sano M, Kyshida K, Takahashi M, Ohishi T, Okada M and Inoue T (1994) Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis. Br J Cancer 70; 701-703
-
(1994)
Br J Cancer
, vol.70
, pp. 701-703
-
-
Sano, M.1
Kyshida, K.2
Takahashi, M.3
Ohishi, T.4
Okada, M.5
Inoue, T.6
-
21
-
-
0027384926
-
Changes of bone metabolic markers in patients with bone metastases: Clinical significance in assessing bone response to chemotherapy
-
Wada S, Katayama Y, Yasutomo Y, Kugai N and Nagata N (1993). Changes of bone metabolic markers in patients with bone metastases: clinical significance in assessing bone response to chemotherapy. Intern Med 32: 611-618
-
(1993)
Intern Med
, vol.32
, pp. 611-618
-
-
Wada, S.1
Katayama, Y.2
Yasutomo, Y.3
Kugai, N.4
Nagata, N.5
|